The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis.

BMC Cancer
George PeridesJulian K Wu

Abstract

Patients with metastatic tumors to the brain have a very poor prognosis. Increased metastatic potential has been associated with the fibrinolytic system. We investigated the role of the fibrinolytic enzyme plasmin in tumor cell migration across brain endothelial cells and growth of brain metastases in an experimental metastatic melanoma model. Metastatic tumors to the brain were established by direct injection into the striatum or by intracarotid injection of B16F10 mouse melanoma cells in C57Bl mice. The role of plasminogen in the ability of human melanoma cells to cross a human blood-brain barrier model was studied on a transwell system. Wild type mice treated with the plasmin inhibitor epsilon-aminocaproic acid (EACA) and plg-/- mice developed smaller tumors and survived longer than untreated wild type mice. Tumors metastasized to the brain of wild type mice treated with EACA and plg-/- less efficiently than in untreated wild type mice. No difference was observed in the tumor growth in any of the three groups of mice. Human melanoma cells were able to cross the human blood-brain barrier model in a plasmin dependent manner. Plasmin facilitates the development of tumor metastasis to the brain. Inhibition of the fibrinolytic sy...Continue Reading

References

Oct 29, 1979·Biochemical and Biophysical Research Communications·W B ButlerT L Jorgensen
Jul 1, 1992·Biological Chemistry Hoppe-Seyler·M SchmittH Graeff
Oct 1, 1991·The Journal of Clinical Investigation·J D VassalliD Belin
Nov 15, 1989·International Journal of Cancer. Journal International Du Cancer·G SchackertI J Fidler
Feb 1, 1986·Journal of Neurosurgery·R SawayaJ M Tew
Apr 15, 1988·International Journal of Cancer. Journal International Du Cancer·G Schackert, I J Fidler
Jan 1, 1993·Journal of Neuro-oncology·U P ThorgeirssonD E Gomez
Jul 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E F PlowJ L Hoover-Plow
Oct 1, 1995·Journal of Neurosurgery·R K BindalS H Taylor
Feb 1, 1995·Clinical Neurology and Neurosurgery·J B Posner, J Dalmau
Jan 1, 1996·Cancer Investigation·R A Patchell
Jul 29, 1996·International Journal of Cancer. Journal International Du Cancer·R H Xing, S A Rabbani
Dec 11, 1995·International Journal of Cancer. Journal International Du Cancer·S A RabbaniA P Mazar
Mar 28, 1997·International Journal of Cancer. Journal International Du Cancer·A Stahl, B M Mueller
Mar 4, 2000·International Journal of Cancer. Journal International Du Cancer·T MaguireM J Duffy
Mar 9, 2000·Seminars in Arthritis and Rheumatism·M L Barilla, S E Carsons
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Michael PrausRobert D Gerard
Nov 7, 2003·Current Molecular Medicine·R A CairnsR P Hill
Jun 19, 2004·Cancer Research·Yasushi ShintaniNariaki Matsuura

❮ Previous
Next ❯

Citations

Jan 17, 2013·Clinical & Experimental Metastasis·Inderjit DaphuFrits Thorsen
Jun 12, 2009·PloS One·W Shawn CarbonellRuth Muschel
Nov 20, 2014·International Journal of Molecular Sciences·Miroslava DidiasovaDariusz Zakrzewicz
Oct 26, 2012·Journal of Biomedicine & Biotechnology·Elena I Deryugina, James P Quigley
Jan 25, 2013·International Journal of Molecular Sciences·Imola WilhelmIstván A Krizbai
Jan 1, 2010·Cancers·William E DamskyMarcus Bosenberg
Sep 19, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Imola WilhelmIstván A Krizbai
Sep 1, 2018·Bioscience Reports·Dolores A Ayón-NúñezJuan P Laclette
Nov 20, 2008·Pigment Cell & Melanoma Research·Yannève RollandRichard Béliveau
Oct 24, 2013·Pigment Cell & Melanoma Research·Imola WilhelmIstván A Krizbai
Jun 3, 2015·Biology of the Cell·Kinga G BlecharzPeter Vajkoczy
Oct 1, 2013·Cancer Control : Journal of the Moffitt Cancer Center·Rajappa S KenchappaPeter A Forsyth
Mar 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Diane PalmieriPatricia S Steeg
May 15, 2013·The American Journal of Pathology·Lukxmi BalathasanRuth J Muschel
Jan 19, 2010·Experimental and Molecular Pathology·Meena SharmaMahesh C Sharma

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
dissecting
transfection
xenograft

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.